Index of /~dosen/repository/hartini

[ICO]NameLast modifiedSizeDescription

[PARENTDIR]Parent Directory   -  
[   ]accumulation.pdf 2022-12-12 02:21 909K 
[   ]aktivitas.pdf 2022-12-12 02:34 1.4M 
[   ]antagonistic.pdf 2022-12-12 02:24 1.2M 
[   ]antibacterial.pdf 2022-12-12 02:31 2.0M 
[   ]antibakteri.pdf 2022-12-12 03:40 11M 
[   ]anticancer.pdf 2022-12-12 03:20 2.3M 
[   ]biflavonoid.pdf 2022-12-12 02:50 5.1M 
[   ]brotowali.pdf 2022-12-12 03:08 1.5M 
[   ]comparison.pdf 2022-12-12 02:26 2.8M 
[   ]dissolution.pdf 2022-12-12 02:59 1.6M 
[   ]effect.pdf 2022-12-12 03:34 114M 
[   ]ekstrak.pdf 2022-12-12 03:38 12M 
[   ]farmakognisi.pdf 2022-12-12 02:07 5.3M 
[   ]immunomodulatory.pdf 2022-12-12 03:23 4.8M 
[   ]implementasi.pdf 2022-12-12 02:11 926K 
[   ]influence.pdf 2022-12-12 03:15 1.6M 
[   ]inulin.pdf 2022-12-12 03:45 758K 
[   ]isocratic.pdf 2022-12-12 02:51 1.6M 
[   ]korespondensi-accumu..>2022-12-14 22:21 108K 
[   ]korespondensi-antago..>2022-12-14 22:24 204K 
[   ]korespondensi-antiba..>2022-12-14 23:26 165K 
[   ]korespondensi-antica..>2022-12-15 00:02 184K 
[   ]korespondensi-biflav..>2022-12-14 23:31 263K 
[   ]korespondensi-brotow..>2022-12-14 23:42 311K 
[   ]korespondensi-compar..>2022-12-14 22:26 200K 
[   ]korespondensi-dissol..>2022-12-14 23:41 264K 
[   ]korespondensi-influe..>2022-12-14 21:46 390K 
[   ]korespondensi-inulin..>2022-12-14 22:11 271K 
[   ]korespondensi-isocra..>2022-12-14 23:34 198K 
[   ]korespondensi-potenc..>2022-12-14 22:08 259K 
[   ]korespondensi-repell..>2022-12-14 21:15 1.7M 
[   ]korespondensi-sambil..>2022-12-14 23:37 158K 
[   ]korespondensi-spectr..>2022-12-14 23:06 319K 
[   ]korespondensi-vivo.pdf 2022-12-14 22:18 233K 
[   ]peraturan.pdf 2022-12-12 03:12 1.4M 
[   ]potency.pdf 2022-12-12 03:43 1.3M 
[   ]regulasi.pdf 2022-12-12 03:47 5.2M 
[   ]repellent.pdf 2022-12-12 02:37 973K 
[   ]sambiloto.pdf 2022-12-12 02:53 1.5M 
[   ]sediaan.pdf 2022-12-12 02:46 3.2M 
[   ]similarity-accumulat..>2022-12-12 02:21 795K 
[   ]similarity-aktivitas..>2022-12-12 02:33 1.2M 
[   ]similarity-antagonis..>2022-12-12 02:23 2.0M 
[   ]similarity-antibacte..>2022-12-12 02:31 1.5M 
[   ]similarity-antibakte..>2022-12-12 03:40 2.5M 
[   ]similarity-anticance..>2022-12-12 03:20 3.9M 
[   ]similarity-biflavono..>2022-12-12 02:49 5.2M 
[   ]similarity-brotowali..>2022-12-12 03:08 1.0M 
[   ]similarity-compariso..>2022-12-12 02:25 3.3M 
[   ]similarity-dissoluti..>2022-12-12 02:58 1.0M 
[   ]similarity-effect.pdf 2022-12-12 03:27 928K 
[   ]similarity-ekstrak.pdf 2022-12-12 03:37 2.0M 
[   ]similarity-farmakogn..>2022-12-12 01:49 40M 
[   ]similarity-immunomod..>2022-12-12 03:23 1.9M 
[   ]similarity-implement..>2022-12-12 02:10 1.7M 
[   ]similarity-influence..>2022-12-12 03:15 1.6M 
[   ]similarity-inulin.pdf 2022-12-12 03:45 1.1M 
[   ]similarity-isocratic..>2022-12-12 02:51 2.4M 
[   ]similarity-peraturan..>2022-12-12 03:12 1.8M 
[   ]similarity-potency.pdf 2022-12-12 03:42 1.3M 
[   ]similarity-regulasi.pdf2022-12-12 03:47 1.5M 
[   ]similarity-repellent..>2022-12-12 02:35 3.1M 
[   ]similarity-sambiloto..>2022-12-12 02:53 1.0M 
[   ]similarity-sediaan.pdf 2022-12-12 02:45 3.4M 
[   ]similarity-spectrosc..>2022-12-12 02:27 1.7M 
[   ]similarity-toxicity.pdf2022-12-12 02:29 3.0M 
[   ]similarity-uji.pdf 2022-12-12 02:13 2.3M 
[   ]similarity-vivo.pdf 2022-12-12 02:18 2.0M 
[   ]spectroscopy.pdf 2022-12-12 02:28 509K 
[   ]toxicity.pdf 2022-12-12 02:29 2.6M 
[   ]uji.pdf 2022-12-12 02:14 1.6M 
[   ]vivo.pdf 2022-12-12 02:18 392K